Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis

Background: Glatiramer acetate (GA, Copaxone(®)) has beneficial effects on the clinical course of relapsing-remitting multiple sclerosis (RRMS). However, the exact molecular mechanisms of GA effects are only partially understood. Objective: To characterized GA molecular effects in RRMS patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Achiron, Anat, Feldman, Anna, Gurevich, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2009
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835057/
https://www.ncbi.nlm.nih.gov/pubmed/19893201
http://dx.doi.org/10.3233/DMA-2009-0651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835057/
https://www.ncbi.nlm.nih.gov/pubmed/19893201
http://dx.doi.org/10.3233/DMA-2009-0651

Ejemplares similares